HUYABIO International reports positive Phase 3 trial results for HBI-8000 and nivolumab combination
ImmunoForge to participate in BIO-Europe 2026
IHI and Bristol Myers Squibb launch initiative to expand cancer clinical trial access
Summit Therapeutics and ECOG-ACRIN launch Phase II/III trial collaboration for biliary tract cancer
Oracle partners AstraZeneca for AI-enabled healthcare innovation
Telix and Ekalia to develop US astatine-211 production
GSK reports 61% response rate for investigational lung cancer drug
IBA and Framatome establish joint venture to scale up Astatine-211 production
SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC
EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer
Telix to present 20 abstracts on cancer theranostics at EANM Congress
CelLBxHealth secures USD65,000 pharmaceutical research contract
Racura Oncology receives approval for RC220 trial to proceed to higher dose